GLP-1-Based Therapies in Type 1 Diabetes: Emerging Evidence on Cardiovascular, Renal, and Safety Outcomes.

Tentolouris A, Popovic DS, Liarakos AL, Briasoulis A, Papanas N, Koufakis T.

Open source

DOI
10.1111/dom.71045
Published
2026-06-30
Container
Diabetes Obes Metab
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/dom.71045,
  title = {GLP-1-Based Therapies in Type 1 Diabetes: Emerging Evidence on Cardiovascular, Renal, and Safety Outcomes.},
  author = {Tentolouris A and  Popovic DS and  Liarakos AL and  Briasoulis A and  Papanas N and  Koufakis T.},
  year = {2026},
  journal = {Diabetes Obes Metab},
  doi = {10.1111/dom.71045},
  url = {https://doi.org/10.1111/dom.71045}
}

RIS

TY  - JOUR
TI  - GLP-1-Based Therapies in Type 1 Diabetes: Emerging Evidence on Cardiovascular, Renal, and Safety Outcomes.
AU  - Tentolouris A
AU  -  Popovic DS
AU  -  Liarakos AL
AU  -  Briasoulis A
AU  -  Papanas N
AU  -  Koufakis T.
PY  - 2026
JO  - Diabetes Obes Metab
DO  - 10.1111/dom.71045
UR  - https://doi.org/10.1111/dom.71045
ER  - 

APA

A, T., DS, P., AL, L., A, B., N, P., & T., K. (2026). GLP-1-Based Therapies in Type 1 Diabetes: Emerging Evidence on Cardiovascular, Renal, and Safety Outcomes.. Diabetes Obes Metab. https://doi.org/10.1111/dom.71045

Source records